The concept of innovative drugs continues to strengthen, with Wanbang Pharmaceutical reaching a 20cm limit-up.

The concept of innovative drugs has continued to strengthen during trading, with Wanbang Pharmaceutical hitting the 20% daily limit. Previously, Baihua Pharmaceutical achieved six consecutive limit increases, while Harbin Pharmaceutical and Ganli Pharmaceutical also hit the limit. Zhendong Pharmaceutical, Borui Pharmaceutical, and Maiwei Biotech have surged over 10%.